The patients were randomly allocated into two groups , and during EIS sessions , one group was administered proton pump inhibitor ( PPI ) ( Rabeprazole @ mg a person once a day ) , while the other received histamine H@ receptor antagonist ( H@-blocker ) ( famotidine @ mg a person , twice a day ) .